Dobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) and cholinergic.
Metabolic disorders are the most severe adverse drug reactions (ADRs) and lead to cardiovascular
BULYGIN, K.V.,
BEERAKA NARASIMHA M.,
SAITGAREEVA, AIGUL R.,
NIKOLENKO, V.N.,
GAREEV, ILGIZ,
BEYLERLI, OZAL,
AKHMADEEVA, LEILA R.,
MIKHALEVA, L.M.,
TORRES SOLIS, LUIS FERNANDO,
SOLÍS, HERRERA ARTURO,
AVILA-RODRIGUEZ, MARCO F.,
SOMASUNDARAM, SIVA G.,
KIRKLAND, CECIL E.,
ALIEV, GJUMRAKCH (2020) RNAs in the regulation of stroke risk factors viz., arterial hypertension,
metabolic disorders, and atherosclerosis
. Inflammation plays a key role in diabetes pathophysiology and associated
metabolic disorders; thus, interest